The global digital therapeutics market is projected to be worth over USD 8.86 billion by 2030,

January 13, 2021

Roots Analysis has done a detailed study on “Digital Health Market: Focus on Digital Therapeutics (2nd Edition), 2020-2030 (Based on Type of Solution (Software Solution, Gaming Solution and Combination Solution), Type of Therapy (Curative and Preventive), and Purpose of Solution (Medication Replacement and Medication Augmentation” covering key aspects of the industry’s evolution and identifying potential future growth opportunities.


To order this 500+ page report, which features 160+ figures and 200+ tables, please visit this link


Key Market Insights

  • Eminent representatives from companies across the world attest to the fact that there is growing interest in the digital therapeutics market, highlighting the prevalent and anticipated trends in R&D and adoption
  • Over 100 industry players are engaged in evaluating the potential of several prescription (validated through clinical research) digital therapeutic solutions to prevent / treat various chronic diseases
  • The pipeline features a variety of digital health applications and therapy solutions that are in different stages of development, being investigated for diverse purposes, across a wide-range of clinical conditions
  • These solutions have demonstrated applicability across more than 20 therapeutic areas; several products have been marketed / approved for the treatment or prevention of mental health problems and metabolic disorders
  • In pursuit of a competitive edge, digital therapeutic solution developers are focusing on the integration of advanced features into their respective products and affiliated offerings
  • In the last few years, over 220 clinical trials evaluating the potential benefits of digital therapeutics in close to 80,000 patients, have been registered; most of these were / are being conducted at various centers in the US
  • Apart from the clinical benefit, cost is another key determinant of the acceptance and adoption of such novel interventions; pricing strategy matrix is likely to assist players to evaluate competitive market prices for solutions


For more information, please visit


Table of Contents



1.1.       Scope of the Report

1.2.       Research Methodology

1.3.       Chapter Outlines





3.1        Chapter Overview

3.2.       Digitization in the Healthcare Sector

3.3.       Next-Generation Healthcare Solutions


3.4.       Key Concepts Associated with Digital Health Solutions

3.4.1.    Cognitive Behavioral Therapy (CBT)

3.4.2.    Internet of Things (IoT)

3.4.3.    Big Data

3.4.4.    Artificial Intelligence (AI)

3.4.5.    Gamification


3.5.       Overview of Digital Therapeutics

3.5.1.    Key Strategic Initiatives Digital Therapeutics Alliance (DTA) Personal Connected Health (PCH) Alliance Programs Initiated by The Centers for Disease Control and Prevention (CDC) Health Insurance Portability and Accountability Act (HIPAA) National Health Service (NHS) Guidelines United States Food and Drug Administration (USFDA) Regulations for Digital Therapeutics


3.5.2.    Product Development and Commercialization Path for Digital Therapeutics Discovery and Preclinical Phase Clinical Trials and Validation Involving Insurance Providers / Payers Distribution and Marketing


Contact Details

Gaurav Chaudhary

+1 (415) 800 3415


Article Categories:

Leave a Comment